Market Capitalization (Millions $) |
14 |
Shares
Outstanding (Millions) |
11 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-9 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Renovorx Inc
Renovorx Inc is a medical technology company that develops innovative solutions for the treatment of cardiovascular diseases. The company specializes in developing catheter-based therapies, such as drug-coated balloons and stents, to address various cardiovascular conditions, including peripheral artery disease and coronary artery disease. Renovorx Inc aims to improve patient outcomes by providing minimally invasive and effective treatment options. Through its cutting-edge technologies, the company strives to revolutionize the field of cardiovascular interventions and enhance the quality of life for patients.
Company Address: 4546 El Camino Real Los Altos 94022 CA
Company Phone Number: 284-4433 Stock Exchange / Ticker: NASDAQ RNXT
RNXT is expected to report next financial results on March 30, 2024. |
|
|